Literature DB >> 33717756

Purpura Fulminans in a Patient With Septic Shock due to Escherichia coli Bacteremia With Emphysematous Pyelitis.

Maria Del Mar Morales Hernandez1, Michael Carranza2, Bijal Patel2, Joshua Calvert2, Ghania Masri2.   

Abstract

Purpura fulminans (PF) is a rapidly fatal disorder predominantly encountered in patients with an acquired deficiency of physiologic anticoagulants due to severe sepsis and septic shock with disseminated intravascular coagulation (DIC). This consumptive process eventually leads to widespread thrombosis, hemorrhagic necrosis, and gangrene. Rapid identification followed by aggressive management of the underlying etiology with a multidisciplinary team is critical to prevent long-term organ dysfunction, disability from amputation, and death. While bleeding is a common finding in DIC, anticoagulation must be considered if PF is present. We report a case of Escherichia coli--associated emphysematous pyelitis leading to bacteremia, septic shock, and PF with small- and medium-sized vessel thrombosis and acral ischemia.
Copyright © 2021, Morales Hernandez et al.

Entities:  

Keywords:  disseminated intravascular coagulation; escherichia coli; purpura fulminans; symmetric peripheral gangrene

Year:  2021        PMID: 33717756      PMCID: PMC7952243          DOI: 10.7759/cureus.13249

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

Review 1.  Ischemic Limb Gangrene with Pulses.

Authors:  Theodore E Warkentin
Journal:  N Engl J Med       Date:  2015-08-13       Impact factor: 91.245

Review 2.  Supportive management strategies for disseminated intravascular coagulation. An international consensus.

Authors:  Alessandro Squizzato; Beverley J Hunt; Gary T Kinasewitz; Hideo Wada; Hugo Ten Cate; Jecko Thachil; Marcel Levi; Vicente Vicente; Armando D'Angelo; Marcello Di Nisio
Journal:  Thromb Haemost       Date:  2015-12-17       Impact factor: 5.249

Review 3.  Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients.

Authors:  Theodore E Warkentin
Journal:  Hamostaseologie       Date:  2019-01-09       Impact factor: 1.778

Review 4.  Purpura fulminans in sepsis.

Authors:  Alex P Betrosian; Tom Berlet; Banwari Agarwal
Journal:  Am J Med Sci       Date:  2006-12       Impact factor: 2.378

Review 5.  Purpura fulminans: recognition, diagnosis and management.

Authors:  E Chalmers; P Cooper; K Forman; C Grimley; K Khair; A Minford; M Morgan; A D Mumford
Journal:  Arch Dis Child       Date:  2011-01-12       Impact factor: 3.791

6.  The skin in disseminated intravascular coagulation. Prospective analysis of thirty-six cases.

Authors:  S J Robboy; M C Mihm; R W Colman; J D Minna
Journal:  Br J Dermatol       Date:  1973-03       Impact factor: 9.302

7.  Escherichia coli Bacteremia-induced Purpura Fulminans: A Case Report.

Authors:  Mohamed Ahmed; Michael Samotowka; Saba Habis; Ahmed Mahmoud; Rasha Saeed
Journal:  Cureus       Date:  2018-11-26

Review 8.  Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy.

Authors:  D I Feinstein
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

9.  Protein C, protein S and C4b-binding protein in severe infection and septic shock.

Authors:  J F Hesselvik; J Malm; B Dahlbäck; M Blombäck
Journal:  Thromb Haemost       Date:  1991-02-12       Impact factor: 5.249

Review 10.  Disseminated intravascular coagulation.

Authors:  A Venugopal
Journal:  Indian J Anaesth       Date:  2014-09
View more
  1 in total

1.  A Rare Cause of a Rare Disorder: E. coli-Induced Purpura Fulminans Secondary to Urinary Tract Infection.

Authors:  Jacob Lowry; Edva Noel
Journal:  Case Rep Crit Care       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.